Sell QTTB now. The Phase 2a headline is strong, but the stock is already up ~81% and nearly 6x YTD, with RSI in the ...

Bio-Techne Corporation, a global provider of life science tools, reagents, and diagnostic products, today announced the ...

Spear Bio, an innovator in ultrasensitive protein biomarker detection, today announced plans to unveil new SPEAR immunoassay ...

Covation Biomaterials LLC ("CovationBio®") is showcasing its two new bio-based innovations, Xatryx® and Sorona® elasterell-p fiber, at this year's Functional Fabric Fair in New York City, July 7–9, ...

Kerala's declining research institutions threaten its potential in the bio-economy, highlighting the need for renewed focus ...

Q32 Bio (NASDAQ:QTTB) reported positive 36-week top-line results from Part B of its SIGNAL-AA Phase 2a clinical trial evaluating bempikibart in patients with severe and very severe alopecia areata, a ...

Palisade Bio offers a speculative early-stage opportunity, advancing PALI-2108, a gut-restricted PDE4 inhibitor for UC and ...

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced that Carol Lou will retire as President and Chief Executive Officer of Takara Bio USA on July 10 ...

Just a plain BIOS update can be enough to give your PC a second wind.